News & Updates

How effective is neurodevelopmental therapy in kids with cerebral palsy?

03 Jun 2022

When it comes to treating children with cerebral palsy, neurodevelopmental therapy (NDT) appears to produce smaller improvements in motor function compared with activity-based and body structure and function interventions, according to a study. Furthermore, NDT is no better than control, and higher-dose is not more effective than lower-dose NDT.

How effective is neurodevelopmental therapy in kids with cerebral palsy?

03 Jun 2022

Cannabidivarin safe, reduces seizure frequency in paediatric MECP2-related Rett syndrome

01 Jun 2022

Treatment with a nonhallucinogenic phytocannabinoid, cannabidivarin, is well tolerated in children with Rett syndrome (RTT), according to data from a phase 1 trial. Moreover, it improves seizure control in those whose disease is caused by methyl-CpG-binding protein 2 (MECP2) pathogenic variants.

Cannabidivarin safe, reduces seizure frequency in paediatric MECP2-related Rett syndrome

01 Jun 2022

Incontinence training with urotherapy helps children with cerebral palsy

31 May 2022

In the treatment of urinary incontinence, urotherapy appears to be effective in children with cerebral palsy, helping reduce symptoms although at a slower rate compared with their typically developing counterparts, according to a study.

Incontinence training with urotherapy helps children with cerebral palsy

31 May 2022

MS patients on certain DMTs may have limited protection from COVID-19 vax

30 May 2022 by

The overall rate of hospitalization for COVID-19 is low among patients with multiple sclerosis (MS) treated with disease-modifying therapies (DMTs) who have been vaccinated against COVID-19, according to a prospective study from England. However, patients on ocrelizumab or fingolimod have elevated hospitalization rates.

MS patients on certain DMTs may have limited protection from COVID-19 vax

30 May 2022

Auditory stimulation enhances brain activity during sleep in older adults

27 May 2022 by

Though auditory stimulation can effectively and remotely improve slow wave activity during sleep in older adults, its effects vary greatly between different individuals, according to a recent study.

Auditory stimulation enhances brain activity during sleep in older adults

27 May 2022

Singe sensor on foot sole predicts gait freezing in Parkinson’s disease

26 May 2022 by

A single plantar pressure sensor device, when placed on the least affected side (LAS), helps predict freezing of gait (FOG) in patients with Parkinson’s disease (PD), according to a recent study.

Singe sensor on foot sole predicts gait freezing in Parkinson’s disease

26 May 2022

Headband device feasible, acceptable for sleep measurements in chronic pain patients

25 May 2022 by

People suffering from chronic pain find the Dreem 2, a novel headband-type wearable device, satisfactory for the measurement of sleep parameters, according to a recent study.

Headband device feasible, acceptable for sleep measurements in chronic pain patients

25 May 2022

Onasemnogene abeparvovec for spinal muscular atrophy safe in heavier babies

24 May 2022

Babies who weigh ≥8.5 kg can safely be administered with onasemnogene abeparvovec for the treatment of spinal muscular atrophy, a new study has found.

Onasemnogene abeparvovec for spinal muscular atrophy safe in heavier babies

24 May 2022

Cranberries sharpen memory, neural function in healthy seniors

24 May 2022 by

Eating a small cup of cranberries daily is apparently good for the brain, enhancing memory consolidation and retrieval for everyday events as well as neural functioning in healthy older adults, as shown in a recent study.

Cranberries sharpen memory, neural function in healthy seniors

24 May 2022

‘1-2-3-4-day rule’: Initiating DOACs according to stroke severity may be the way to go

23 May 2022 by

Following nonvalvular atrial fibrillation (NVAF)-associated stroke events, a graded increase in delay in direct oral anticoagulants (DOACs) initiation of between 1 and 4 days, depending on the severity of the index event, appears to be effective for recurrent stroke prevention and does not compromise safety both in Asians and Europeans, according to a recent study.

‘1-2-3-4-day rule’: Initiating DOACs according to stroke severity may be the way to go

23 May 2022

News & Updates

Filter by Specialty:

Specialty:

How effective is neurodevelopmental therapy in kids with cerebral palsy?

How effective is neurodevelopmental therapy in kids with cerebral palsy?

Cannabidivarin safe, reduces seizure frequency in paediatric MECP2-related Rett syndrome

Cannabidivarin safe, reduces seizure frequency in paediatric MECP2-related Rett syndrome

Incontinence training with urotherapy helps children with cerebral palsy

Incontinence training with urotherapy helps children with cerebral palsy

MS patients on certain DMTs may have limited protection from COVID-19 vax

MS patients on certain DMTs may have limited protection from COVID-19 vax

Auditory stimulation enhances brain activity during sleep in older adults

Auditory stimulation enhances brain activity during sleep in older adults

Singe sensor on foot sole predicts gait freezing in Parkinson’s disease

Singe sensor on foot sole predicts gait freezing in Parkinson’s disease

Headband device feasible, acceptable for sleep measurements in chronic pain patients

Headband device feasible, acceptable for sleep measurements in chronic pain patients

Onasemnogene abeparvovec for spinal muscular atrophy safe in heavier babies

Onasemnogene abeparvovec for spinal muscular atrophy safe in heavier babies

Cranberries sharpen memory, neural function in healthy seniors

Cranberries sharpen memory, neural function in healthy seniors

‘1-2-3-4-day rule’: Initiating DOACs according to stroke severity may be the way to go

‘1-2-3-4-day rule’: Initiating DOACs according to stroke severity may be the way to go